Literature DB >> 18927083

Mammalian phosphomannomutase PMM1 is the brain IMP-sensitive glucose-1,6-bisphosphatase.

Maria Veiga-da-Cunha1, Wendy Vleugels, Pushpa Maliekal, Gert Matthijs, Emile Van Schaftingen.   

Abstract

Glucose 1,6-bisphosphate (Glc-1,6-P(2)) concentration in brain is much higher than what is required for the functioning of phosphoglucomutase, suggesting that this compound has a role other than as a cofactor of phosphomutases. In cell-free systems, Glc-1,6-P(2) is formed from 1,3-bisphosphoglycerate and Glc-6-P by two related enzymes: PGM2L1 (phosphoglucomutase 2-like 1) and, to a lesser extent, PGM2 (phosphoglucomutase 2). It is hydrolyzed by the IMP-stimulated brain Glc-1,6-bisphosphatase of still unknown identity. Our aim was to test whether Glc-1,6-bisphosphatase corresponds to the phosphomannomutase PMM1, an enzyme of mysterious physiological function sharing several properties with Glc-1,6-bisphosphatase. We show that IMP, but not other nucleotides, stimulated by >100-fold (K(a) approximately 20 mum) the intrinsic Glc-1,6-bisphosphatase activity of recombinant PMM1 while inhibiting its phosphoglucomutase activity. No such effects were observed with PMM2, an enzyme paralogous to PMM1 that physiologically acts as a phosphomannomutase in mammals. Transfection of HEK293T cells with PGM2L1, but not the related enzyme PGM2, caused an approximately 20-fold increase in the concentration of Glc-1,6-P(2). Transfection with PMM1 caused a profound decrease (>5-fold) in Glc-1,6-P(2) in cells that were or were not cotransfected with PGM2L1. Furthermore, the concentration of Glc-1,6-P(2) in wild-type mouse brain decreased with time after ischemia, whereas it did not change in PMM1-deficient mouse brain. Taken together, these data show that PMM1 corresponds to the IMP-stimulated Glc-1,6-bisphosphatase and that this enzyme is responsible for the degradation of Glc-1,6-P(2) in brain. In addition, the role of PGM2L1 as the enzyme responsible for the synthesis of the elevated concentrations of Glc-1,6-P(2) in brain is established.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18927083      PMCID: PMC2662221          DOI: 10.1074/jbc.M805224200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  32 in total

1.  Regulation of phosphofructokinase by phosphocreatine and phosphorylated glycolytic intermediates.

Authors:  J Krzanowski; F M Matschinsky
Journal:  Biochem Biophys Res Commun       Date:  1969-03-31       Impact factor: 3.575

2.  Glucose- and mannose-1,6-P2 as activators of phosphofructokinase in red blood cells.

Authors:  I A Rose; J V Warms
Journal:  Biochem Biophys Res Commun       Date:  1974-08-19       Impact factor: 3.575

3.  The influence of glucose I,6-diphosphate on the enzymatic activity of pyruvate kinase.

Authors:  J F Koster; R G Slee; G E Staal; T J van Berkel
Journal:  Biochim Biophys Acta       Date:  1972-03-08

4.  Glucose 1,6-diphosphate formation by phosphoglucomutase in mammalian tissues.

Authors:  J V Passonneau; O H Lowry; D W Schulz; J G Brown
Journal:  J Biol Chem       Date:  1969-02-10       Impact factor: 5.157

5.  A specific enzyme for glucose 1,6-bisphosphate synthesis.

Authors:  I A Rose; J V Warms; G Kaklij
Journal:  J Biol Chem       Date:  1975-05-10       Impact factor: 5.157

6.  Kinetic properties and tissular distribution of mammalian phosphomannomutase isozymes.

Authors:  M Pirard; Y Achouri; J F Collet; E Schollen; G Matthijs; E Van Schaftingen
Journal:  Biochem J       Date:  1999-04-01       Impact factor: 3.857

7.  The normal phenotype of Pmm1-deficient mice suggests that Pmm1 is not essential for normal mouse development.

Authors:  K Cromphout; W Vleugels; L Heykants; E Schollen; L Keldermans; R Sciot; R D'Hooge; P P De Deyn; K von Figura; D Hartmann; C Körner; G Matthijs
Journal:  Mol Cell Biol       Date:  2006-08       Impact factor: 4.272

8.  PMM (PMM1), the human homologue of SEC53 or yeast phosphomannomutase, is localized on chromosome 22q13.

Authors:  G Matthijs; E Schollen; M Pirard; M L Budarf; E Van Schaftingen; J J Cassiman
Journal:  Genomics       Date:  1997-02-15       Impact factor: 5.736

9.  The X-ray crystal structures of human alpha-phosphomannomutase 1 reveal the structural basis of congenital disorder of glycosylation type 1a.

Authors:  Nicholas R Silvaggi; Chunchun Zhang; Zhibing Lu; Jianying Dai; Debra Dunaway-Mariano; Karen N Allen
Journal:  J Biol Chem       Date:  2006-03-15       Impact factor: 5.157

10.  Many fructosamine 3-kinase homologues in bacteria are ribulosamine/erythrulosamine 3-kinases potentially involved in protein deglycation.

Authors:  Rita Gemayel; Juliette Fortpied; Rim Rzem; Didier Vertommen; Maria Veiga-da-Cunha; Emile Van Schaftingen
Journal:  FEBS J       Date:  2007-08-06       Impact factor: 5.542

View more
  13 in total

Review 1.  How glycogen sustains brain function: A plausible allosteric signaling pathway mediated by glucose phosphates.

Authors:  Mauro DiNuzzo
Journal:  J Cereb Blood Flow Metab       Date:  2019-06-17       Impact factor: 6.200

2.  Ontogeny of D-mannose transport and metabolism in rat small intestine.

Authors:  Mecedes Cano; Anunciación A Ilundain
Journal:  J Membr Biol       Date:  2010-06-04       Impact factor: 1.843

3.  Changes in the striatal proteome of YAC128Q mice exhibit gene-environment interactions between mutant huntingtin and manganese.

Authors:  Michal Wegrzynowicz; Hunter K Holt; David B Friedman; Aaron B Bowman
Journal:  J Proteome Res       Date:  2012-01-20       Impact factor: 4.466

4.  Evolutionary history and functional diversification of phosphomannomutase genes.

Authors:  Rita Quental; Ana Moleirinho; Luísa Azevedo; António Amorim
Journal:  J Mol Evol       Date:  2010-07-27       Impact factor: 2.395

Review 5.  Towards a therapy for phosphomannomutase 2 deficiency, the defect in CDG-Ia patients.

Authors:  Hudson H Freeze
Journal:  Biochim Biophys Acta       Date:  2009-09

6.  Molecular analysis of phosphomannomutase (PMM) genes reveals a unique PMM duplication event in diverse Triticeae species and the main PMM isozymes in bread wheat tissues.

Authors:  Chunmei Yu; Yiwen Li; Bin Li; Xin Liu; Lifang Hao; Jing Chen; Weiqiang Qian; Shiming Li; Guanfeng Wang; Shiwei Bai; Hua Ye; Huanju Qin; Qianhua Shen; Liangbiao Chen; Aimin Zhang; Daowen Wang
Journal:  BMC Plant Biol       Date:  2010-10-05       Impact factor: 4.215

7.  Genetic and immunohistochemical analysis of HSPA5 in mouse and human retinas.

Authors:  Sumana R Chintalapudi; XiaoFei Wang; Huiling Li; Yin H Chan Lau; Robert W Williams; Monica M Jablonski
Journal:  Mol Vis       Date:  2016-11-10       Impact factor: 2.367

8.  A mutant of phosphomannomutase1 retains full enzymatic activity, but is not activated by IMP: Possible implications for the disease PMM2-CDG.

Authors:  Valentina Citro; Chiara Cimmaruta; Ludovica Liguori; Gaetano Viscido; Maria Vittoria Cubellis; Giuseppina Andreotti
Journal:  PLoS One       Date:  2017-12-19       Impact factor: 3.240

Review 9.  CDG Therapies: From Bench to Bedside.

Authors:  Sandra Brasil; Carlota Pascoal; Rita Francisco; Dorinda Marques-da-Silva; Giuseppina Andreotti; Paula A Videira; Eva Morava; Jaak Jaeken; Vanessa Dos Reis Ferreira
Journal:  Int J Mol Sci       Date:  2018-04-27       Impact factor: 5.923

10.  Biochemical phenotype of a common disease-causing mutation and a possible therapeutic approach for the phosphomannomutase 2-associated disorder of glycosylation.

Authors:  Giuseppina Andreotti; Emilia Pedone; Assunta Giordano; Maria Vittoria Cubellis
Journal:  Mol Genet Genomic Med       Date:  2013-03-27       Impact factor: 2.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.